Walking the telomere plank into cancer

Journal of the National Cancer Institute

Volumn 95, Issue 16, 2003, Pages 1184-1186

  Wong, Kwok Kin ^a   DePinho, Ronald A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DOUBLE STRANDED DNA; PROTEIN P53; TUMOR MARKER;

CANCER GENETICS; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHROMOSOME ABERRATION; CHROMOSOME SIZE; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; EDITORIAL; GENETIC VARIABILITY; HUMAN; IMMUNOSURVEILLANCE; IONIZING RADIATION; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SMOKING; TELOMERE; TUMOR IMMUNITY; TUMOR SUPPRESSOR GENE; ANIMAL; BLADDER TUMOR; CELL TRANSFORMATION; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; HEAD AND NECK TUMOR; KIDNEY TUMOR; LUNG TUMOR; LYMPHOCYTE; METABOLISM; NEOPLASM; NOTE; PRECANCER; PREDICTION AND FORECASTING; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HEAD AND NECK NEOPLASMS; HUMANS; KIDNEY NEOPLASMS; LUNG NEOPLASMS; LYMPHOCYTES; NEOPLASMS; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; TELOMERE; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 0042913370     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djg028     Document Type: Editorial

References (40)

1. Blasco MA, Hahn WC. Evolving views of telomerase and cancer. Trends Cell Biol 2003;13:289-94.
2. Blasco MA. Telomeres in cancer and aging: lessons from the mouse. Cancer Lett 2003;194:183-8.
3. DePinho RA, Wong KK. The age of cancer: telomeres, checkpoints, and longevity. J Clin Invest 2003;111:S9-14.
4. Kim SH, Kaminker P, Campisi J. Telomeres, aging and cancer: in search of a happy ending. Oncogene 2002;21:503-11.
5. Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L, et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 2000;406:641-5.
6. Chin L, Artandi SE, Shen Q, Tam A, Lee SL, Gottlieb GJ, et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 1999;97:527-38.
7. Wong KK, Maser RS, Bachoo RM, Menon J, Carrasco DR, Gu Y, et al. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature 2003;421:643-8.
8. Takagi S, Kinouchi Y, Hiwatashi N, Chida M, Nagashima F, Takahashi S, et al. Telomere shortening and the clinicopathologic characteristics of human colorectal carcinomas. Cancer 1999;86:1431-6.
9. Engelhardt M, Drullinsky P, Guillem J, Moore MA. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Clin Cancer Res 1997;3:1931-41.
10. Yoshida R, Kiyozuka Y, Ichiyoshi H, Senzaki H, Takada H, Hioki K, et al. Change in telomerase activity during human colorectal carcinogenesis. Anticancer Res 1999;19:2167-72.
11. Gisselsson D, Jonson T, Petersen A, Strombeck B, Dal Cin P, Hoglund M, et al. Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors. Proc Natl Acad Sci U S A 2001;98:12683-8.
12. van Heek NT, Meeker AK, Kern SE, Yeo CJ, Lillemoe KD, Cameron JL, et al. Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia. Am J Pathol 2002;161:1541-7.
13. Hiyama E, Hiyama K. Telomerase as tumor marker. Cancer Lett 2003; 194:221-33.
14. Hiyama E, Hiyama K. Clinical utility of telomerase in cancer. Oncogene 2002;21:643-9.
15. Hakin-Smith V, Jellinek DA, Levy D, Carroll T, Teo M, Timperley WR, et al. Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme. Lancet 2003;361:836-8.
16. Brouilette S, Singh RK, Thompson JR, Goodall AH, Samani NJ. White cell telomere length and risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol 2003;23:842-6.
17. Samani NJ, Boultby R, Butler R, Thompson JR, Goodall AH. Telomere shortening in atherosclerosis. Lancet 2001;358:472-3.
18. Obana N, Takagi S, Kinouchi Y, Tokita Y, Sekikawa A, Takahashi S, et al. Telomere shortening of peripheral blood mononuclear cells in coronary disease patients with metabolic disorders. Intern Med 2003;42:150-3.
19. Panossian LA, Porter VR, Valenzuela HF, Zhu X, Reback E, Masterman D, et al. Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol Aging 2003;24:77-84.
20. Cawthon RM, Smith KR, O'Brien E, Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003;361:393-5.
21. Wu X, Amos CI, Zhu Y, Zhao H, Grossman BH, Shay JW, et al. Telomere dysfunction: a potential cancer predisposition factor. 2003; 95:1211-8.
22. Isokawa O, Suda T, Aoyagi Y, Kawai H, Yokota T, Takahashi T, et al. Reduction of telomeric repeats as a possible predictor for development of hepatocellular carcinoma: convenient evaluation by slot-blot analysis. Hepatology 1999;30:408-12.
23. Aikata H, Takaishi H, Kawakami Y, Takahashi S, Kitamoto M, Nakanishi T, et al. Telomere reduction in human liver tissues with age and chronic inflammation. Exp Cell Res 2000;256:578-82.
24. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002;31:339-46.
25. O'Sullivan JN, Bronner MP, Brentnall TA, Finley JC, Shen WT, Emerson S, et al. Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat Genet 2002;32:280-4.
26. Kinouchi Y, Hiwatashi N, Chida M, Nagashima F, Takagi S, Maekawa H, et al. Telomere shortening in the colonic mucosa of patients with ulcerative colitis. J Gastroenterol 1998;33:343-8.
27. Effros RB. Ageing and the immune system. Novartis Found Symp 2001; 235:130-9.
28. Effros RB, Pawelec G. Replicative senescence of T cells: does the Hayflick Limit lead to immune exhaustion? Immunol Today 1997;18:450-4.
29. Burns JB, Lobo ST, Bartholomew BD. In vivo reduction of telomere length in human antigen-reactive memory T cells. Eur J Immunol 2000;30: 1894-901.
30. McIlrath J, Bouffler SD, Samper E, Cuthbert A, Wojcik A, Szumiel I, et al. Telomere length abnormalities in mammalian radiosensitive cells. Cancer Res 2001;61:912-5.
31. Wong KK, Chang S, Weiler SR, Ganesan S, Chaudhuri J, Zhu C, et al. Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation. Nat Genet 2000;26:85-8.
32. Goytisolo FA, Samper E, Martin-Caballero J, Finnon P, Herrera E, Flores JM, et al. Short telomeres result in organismal hypersensitivity to ionizing radiation in mammals. J Exp Med 2000;192:1625-36.
33. Sashida G, Ohyashiki JH, Nakajima A, Sumi M, Kawakubo K, Tauchi T, et al. Telomere dynamics in myelodysplastic syndrome determined by telomere measurement of marrow metaphases. Clin Cancer Res 2003;9: 1489-96.
34. Ohyashiki JH, Sashida G, Tauchi T, Ohyashiki K. Telomeres and telomerase in hematologic neoplasia. Oncogene 2002;21:680-7.
35. Ohyashiki JH, Ohyashiki K, Fujimura T, Kawakubo K, Shimamoto T, Iwabuchi A, et al. Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes. Cancer Res 1994;54:3557-60.
36. Ohyashiki K, Iwama H, Yahata N, Tauchi T, Kawakubo K, Shimamoto T, et al. Telomere dynamics in myelodysplastic syndromes and acute leukemic transformation. Leuk Lymphoma 2001;42:291-9.
37. Ohyashiki JH, Iwama H, Yahata N, Ando K, Hayashi S, Shay JW, et al. Telomere stability is frequently impaired in high-risk groups of patients with myelodysplastic syndromes. Clin Cancer Res 1999;5:1155-60.
38. Nilsson P, Mehle C, Remes K, Roos G. Telomerase activity in vivo in human malignant hematopoietic cells. Oncogene 1994;9:3043-8.
39. Boultwood J, Fidler C, Kusec R, Rack K, Elliott PJ, Atoyebi O, et al. Telomere length in myelodysplastic syndromes. Am J Hematol 1997;56: 266-71.
40. Wu KD, Orme LM, Shaughnessy J Jr, Jacobson J, Barlogie B, Moore MA. Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival. Blood 2003; 101:4982-9.